Outcomes after liver transplantation for patients with hepatocellular carcinoma and a low risk of dropout from the transplant waiting list

Liver Transplantation

Volumn 20, Issue 5, 2014, Pages 627-628

  Mehta, Neil ^a   Dodge, Jennifer L ^b   Roberts, John Paul ^b   Hirose, Ryutaro ^b   Yao, Francis Y ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA FETOPROTEIN;

ALPHA FETOPROTEIN BLOOD LEVEL; CANCER PATIENT; CANCER RECURRENCE; CANCER SURVIVAL; CAUSE OF DEATH; FOLLOW UP; HEPATITIS C; HOSPITAL ADMISSION; HUMAN; LETTER; LIVER CELL CARCINOMA; LIVER TRANSPLANTATION; LOW RISK PATIENT; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; TUMOR VOLUME; CARCINOMA, HEPATOCELLULAR; FEMALE; LIVER NEOPLASMS; MALE; PATIENT DROPOUTS; TRANSPLANTATION;

CARCINOMA, HEPATOCELLULAR; FEMALE; HUMANS; LIVER NEOPLASMS; LIVER TRANSPLANTATION; MALE; PATIENT DROPOUTS; TISSUE AND ORGAN PROCUREMENT; WAITING LISTS;

EID: 84899628301     PISSN: 15276465     EISSN: 15276473     Source Type: Journal    
DOI: 10.1002/lt.23847     Document Type: Letter

References (4)

1. Bazerbachi F, Aby E, Lake JR,. Selecting patients with hepatocellular carcinoma for liver transplantation: who should receive priority? Liver Transpl 2013; 19: 1289-1291.
2. Mehta N, Dodge JL, Goel A, Roberts JP, Hirose R, Yao FY,. Identification of liver transplant candidates with hepatocellular carcinoma and a very low dropout risk: implications for the current organ allocation policy. Liver Transpl 2013; 19: 1343-1353.
3. Cucchetti A, Cescon M, Bertuzzo V, Bigonzi E, Ercolani G, Morelli MC, et al. Can the dropout risk of candidates with hepatocellular carcinoma predict survival after liver transplantation? Am J Transplant 2011; 11: 1696-1704.
4. Berry K, Ioannou GN,. Serum alpha-fetoprotein level independently predicts posttransplant survival in patients with hepatocellular carcinoma. Liver Transpl 2013; 19: 634-645.